Fresh Tracks Therapeutics Statistics Share Statistics Fresh Tracks Therapeutics has 5.97M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 5.97M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 4.14M Failed to Deliver (FTD) Shares 806 FTD / Avg. Volume 30.23%
Short Selling Information The latest short interest is 442, so 0% of the outstanding
shares have been sold short.
Short Interest 442 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.91 and the forward
PE ratio is null.
Fresh Tracks Therapeutics's PEG ratio is
0.01.
PE Ratio -0.91 Forward PE n/a PS Ratio 0.65 Forward PS n/a PB Ratio 0.52 P/FCF Ratio -1.2 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Fresh Tracks Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.98,
with a Debt / Equity ratio of 0.
Current Ratio 6.98 Quick Ratio 6.98 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -1272
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $2M Profits Per Employee $-1.42M Employee Count 4 Asset Turnover 0.69 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 6.82% in the
last 52 weeks. The beta is 1.17, so Fresh Tracks Therapeutics's
price volatility has been higher than the market average.
Beta 1.17 52-Week Price Change 6.82% 50-Day Moving Average 0.81 200-Day Moving Average 0.82 Relative Strength Index (RSI) 76.87 Average Volume (20 Days) 2,666
Income Statement In the last 12 months, Fresh Tracks Therapeutics had revenue of 8.01M
and earned -5.69M
in profits. Earnings per share was -0.96.
Revenue 8.01M Gross Profit 8.01M Operating Income -6.36M Net Income -5.69M EBITDA -5.65M EBIT -5.69M Earnings Per Share (EPS) -0.96
Full Income Statement Balance Sheet The company has 10.87M in cash and 0 in
debt, giving a net cash position of 10.87M.
Cash & Cash Equivalents 10.87M Total Debt n/a Net Cash n/a Retained Earnings -172.16M Total Assets 11.59M Working Capital 9.9M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.34M
and capital expenditures 0, giving a free cash flow of -4.34M.
Operating Cash Flow -4.34M Capital Expenditures n/a Free Cash Flow -4.34M FCF Per Share -0.73
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -79.44% and -71.12%.
Gross Margin 100% Operating Margin -79.44% Pretax Margin -71.12% Profit Margin -71.12% EBITDA Margin -70.55% EBIT Margin -79.44% FCF Margin -54.25%
Dividends & Yields FRTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for FRTX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 5, 2022. It was a
backward
split with a ratio of 1:45.
Last Split Date Jul 5, 2022 Split Type backward Split Ratio 1:45
Scores Altman Z-Score -18.72 Piotroski F-Score 4
